Hinge Health Inc. Class A Common Stock vs MGM Resorts International — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while MGM Resorts International trades at $28.92 (market cap $7.29B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and MGM Resorts International pays a 0.03% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and MGM Resorts International for 92 Days on average.
| HNGE | MGM | |
|---|---|---|
Market Cap | $8.47B | $7.29B |
Volume | 1,624,526 | 4,222,588 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $50.69 |
52-Week Low | $31.17 | $28.96 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $8.09B | $34.59B |
Dividend Yield | — | 0.03% |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
MGM Resorts International (MGM) trades at $29.40, showing modest daily gains of 0.27% but facing significant bearish technical pressure with 19 sell signals versus 5 buy signals. The company maintains stable revenue around $17.5B annually but faces profitability challenges with net margins declining from 11.22% in 2022 to just 1.17% in 2025. Recent market volatility stems from Barry Diller's withdrawn $48.30 per share acquisition offer, causing substantial stock declines despite strong analyst support with 51% buy ratings and a $47.57 consensus target.
MGM presents a compelling valuation case with attractive P/S (0.44) and P/E (17.82) ratios, though near-term headwinds include weak technical momentum and earnings volatility. The stock's 36% discount to analyst targets offers upside potential, but investors must weigh acquisition uncertainty against fundamental stability in the gaming sector. Key catalysts include Q3 2026 earnings on October 28 and potential strategic moves regarding People Inc.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →